Mercy Gilbert Medical Center is a full-service, 212-bed, acute care, not-for-profit hospital providing healthcare to the East Valley of the Phoenix Arizona metropolitan area.

There are 212 beds in Mercy Gilbert Medical Center.

During the past decade, Mercy Gilbert Medical Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Gilbert Medical Center" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Cardiovascular Systems Inc" with 2 trials sponsored, "Stemedica Cell Technologies, Inc." with 2 trials sponsored, "APR Applied Pharma Research s.a." with 1 trials sponsored and "Abbott Medical Devices" with 1 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Gilbert Medical Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "CardioCell LLC" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Gilbert Medical Center" are "Coronary Artery Disease" (8 trials), "Heart Failure" (4 trials), "Myocardial Infarction" (3 trials), "ASCVD" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Mercy Gilbert Medical Center" in a lesser frequency.

Most popular intervention types in "Mercy Gilbert Medical Center" are "Device" (10 trials), "Drug" (10 trials), "Biological" (8 trials), "Other" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)" (1 trials), "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "ARRY-371797 (PF-07265803)" (1 trials) and "Absorb BVS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Gilbert Medical Center" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Gilbert Medical Center". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Mercy Gilbert Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Gilbert Medical Center, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".